Valuation of Swallowing in Patient Sedated for Gastroenteric Endoscopic Procedure
NCT ID: NCT01789424
Last Updated: 2015-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2012-05-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Swallowing will be study by laryngeal fibroscopy and evaluate using Penetration-Aspiration Scale and Aspiration Risk validated in scientific literature.
Aim of the study is to describe swallowing, as an expression of airway protection, in sedated patient. in particular, our purpose is to determine the incidence of moderate-severe and severe swallowing alteration (level 3 or 4 of Aspiration Risk scale).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening and Intervention of Postextubation Dysphagia
NCT03284892
Esophageal Manometry During Recovery From Endotracheal Intubation
NCT05574465
Endoscopy-Assisted Tracheal Intubation Versus Conventional Tracheal Intubation for Endoscopic Submucosal Dissection (ESD): a Prospective Randomized Controlled Study
NCT06730984
The Routine Use of Nasopharyngeal Airway in the Setting of Monitored Anesthesia Care During Gastrointestinal Endoscopy
NCT04123821
Recovery Between NIVATS and Intubated Patients
NCT03711461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During sedation, before starting the gastroenteric endoscopic exam, will be performed a fibroscopic swallowing evaluation made by an expert otolaryngologist.
Fibroscopic evaluation consist of:
* laryngeal fibroscopy to evaluate vocal cord motility
* swallowing trial using 3 blue colored water bolus (3-4ml) and computing a " Penetration-aspiration scale" and an " Aspiration risk scale"
Rosenbek, Robbins et al. A Penetration-Aspiration Scale. Dysphagia 11:93-98, 1996:
1. No penetration in the airway
2. Bolus reaches the airway, it does not reach vocal cords and it is completely eliminated
3. Bolus reaches the airway, it does not reach vocal cords but it is not completely eliminated
4. Bolus reaches the airway, it reaches vocal cords but it is completely eliminated
5. Bolus reaches the airway, it reaches vocal cords and it is not completely eliminated
6. Bolus reaches the airway, it passes trough vocal cords but it is completely eliminated
7. Bolus reaches the airway, it passes trough vocal cords, it is not eliminated but patient strives to expel it
8. Bolus reaches the airway, it passes trough vocal cords, it is not eliminated and patient does not strive to expel it
Daniels e coll.: Clinical Predictors of Dysphagia and Aspiration Risk: Outcome Measures in Acute Stroke Patients. Arch Phys Med Rehab Vol 81, August 2000:
1. Normal swallowing : no aspiration or penetration in the airway
2. Trivial swallowing impairment: oral or pharyngeal impairment that causes occasional airway penetration with rapid clearance
3. Moderate swallowing impairment: oral or pharyngeal impairment that causes consistent airway penetration with stasis into the vestibule or two or less event of aspiration of a similar viscosity aliment
4. Moderate-severe swallowing impairment: oral or pharyngeal impairment that causes an important aspiration of a similar viscosity aliment
5. Severe swallowing impairment: oral or pharyngeal impairment that causes an important aspiration of similar or different viscosity
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* presence of tracheostomy actual or in the past
* severe respiratory deficit
* neurological disease which can compromise swallowing function
* history of surgery for mouth or pharyngeal or esophageal cancer
* history of otolaryngology surgery
* faring-laryngeal radiotherapy
* emergent procedure
* psychic alteration
* patient in therapy with any kind of antidepressant drugs
* insulin dependent diabetes mellitus patient
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ospedale San Raffaele
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Agostoni Massimo
Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale San Raffaele
Milan, Italy, Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gemma M, Pasin L, Oriani A, Agostoni M, Palonta F, Ramella B, Bussi M, Beretta L. Swallowing Impairment During Propofol Target-Controlled Infusion. Anesth Analg. 2016 Jan;122(1):48-54. doi: 10.1213/ANE.0000000000000796.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Swallsed2012
Identifier Type: -
Identifier Source: secondary_id
Swallsed
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.